Realizing the Potential of Genetic Testing

The Promise

At its highest level, genetic testing precisely identifies those who have a predisposition to a genetic disease – as well as those who do not.

It thus promises immense benefits, including:

  • The alleviation of suffering
  • The reduction of health care costs

It focuses screening where it’s truly needed; it enables early intervention; and it facilitates better healthcare planning and management.

The Challenge

The genetic basis of many diseases is yet to be discovered. However, even for diseases where genes have been identified, the promise of genetic testing is still largely unrealized.

Broadly speaking, modern health systems lack the integrated capacity to:

  • Identify genetic diseases with a high potential for test development
  • Develop and optimize genetic analysis in clinical labs that yields consistent, accurate and economically viable results
  • Earn clinician acceptance and payor approval
  • Develop effective, client-sensitive delivery systems

Solutions by Sequence

We are pioneers in the development of accurate, economic testing methods and optimized delivery models. Our tests, lab services and networks of families and clinicians set the global standard.

Solutions is recognized for achievements in Retinoblastoma and Hereditary Hemorrhagic Telangiectasia. We have recently launched testing for Von Hippel-Lindau Syndrome in partnership with Toronto’s Mt.Sinai Hospital.

We are accelerating our development capacity, targeting strategically rewarding genes and pursuing new partnerships.

We invite your interest.  Please e-mail us or call us at (416) 603-5597.

 

 

 

Submit Samples

Von Hippel Lindau (VHL) Syndrome

 

 

 

Clinical Testing 
Services

  Retinoblastoma
  Hereditary Hemorrhagic Telangiectasia
  Von Hippel Lindau (VHL) Syndrome